Search research articles
Contact Us
Filters
Showing results (171-180 of 687) with videos related to
Page
of 69
Sort By:
Journal of the American Heart Association
|
March 21, 2022
Generalizability of FIGARO-DKD and FIDELIO-DKD Trial Criteria to the US Population Eligible for Finerenone
Nicholas Chiu, Rahul Aggarwal, George L Bakris, et al.
Journal of the American College of Cardiology
|
October 29, 2011
Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy
Patrick Rossignol, Joël Ménard, Renaud Fay, et al.
European Journal of Heart Failure
|
April 13, 2017
Tailoring mineralocorticoid receptor antagonist therapy in heart failure patients: are we moving towards a personalized approach?
João Pedro Ferreira, Robert J Mentz, Anne Pizard, et al.
Journal of Patient Experience
|
February 7, 2025
Examining Symptom Management and Quality of Life of Loop Diuretic-Induced Overactive Bladder Among Heart Failure Patients: Physician and Patient Perspectives
Xin Pan, Christopher S Wilcox, Bertram Pitt, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
April 8, 2020
Prognostic impact of plasma volume estimated from hemoglobin and hematocrit in heart failure with preserved ejection fraction
Masatake Kobayashi, Nicolas Girerd, Kevin Duarte, et al.
Journal of the American College of Cardiology
|
August 23, 2003
Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD)
Michael Domanski, James Norman, Bertram Pitt, et al.
European Journal of Pharmacology
|
March 5, 2021
Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19
Bertram Pitt, Nadia R Sutton, Zhong Wang, et al.
Nefrologia
|
November 23, 2025
Towards a better prevention in cardio-kidney metabolic syndrome: Role of aldosterone and albuminuria
Luis M Ruilope, Bertram Pitt, Alejandro de la Sierra, et al.
Journal of the American College of Cardiology
|
July 30, 2025
Aldosterone and Aldosterone Modulation in Cardio-Kidney Diseases
Francesco Fioretti, Jeffrey M Testani, Maria Clarissa Tio, et al.
Journal of Hypertension
|
May 17, 2017
Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data
Thomas D Giles, John R Cockcroft, Bertram Pitt, et al.
Page
of 69
Search research articles
Search
Showing results (171-180 of 687) with videos related to
Sort By:
Page
of 69
Journal of the American Heart Association
|
March 21, 2022
Generalizability of FIGARO-DKD and FIDELIO-DKD Trial Criteria to the US Population Eligible for Finerenone
Nicholas Chiu, Rahul Aggarwal, George L Bakris, et al.
Journal of the American College of Cardiology
|
October 29, 2011
Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy
Patrick Rossignol, Joël Ménard, Renaud Fay, et al.
European Journal of Heart Failure
|
April 13, 2017
Tailoring mineralocorticoid receptor antagonist therapy in heart failure patients: are we moving towards a personalized approach?
João Pedro Ferreira, Robert J Mentz, Anne Pizard, et al.
Journal of Patient Experience
|
February 7, 2025
Examining Symptom Management and Quality of Life of Loop Diuretic-Induced Overactive Bladder Among Heart Failure Patients: Physician and Patient Perspectives
Xin Pan, Christopher S Wilcox, Bertram Pitt, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
April 8, 2020
Prognostic impact of plasma volume estimated from hemoglobin and hematocrit in heart failure with preserved ejection fraction
Masatake Kobayashi, Nicolas Girerd, Kevin Duarte, et al.
Journal of the American College of Cardiology
|
August 23, 2003
Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD)
Michael Domanski, James Norman, Bertram Pitt, et al.
European Journal of Pharmacology
|
March 5, 2021
Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19
Bertram Pitt, Nadia R Sutton, Zhong Wang, et al.
Nefrologia
|
November 23, 2025
Towards a better prevention in cardio-kidney metabolic syndrome: Role of aldosterone and albuminuria
Luis M Ruilope, Bertram Pitt, Alejandro de la Sierra, et al.
Journal of the American College of Cardiology
|
July 30, 2025
Aldosterone and Aldosterone Modulation in Cardio-Kidney Diseases
Francesco Fioretti, Jeffrey M Testani, Maria Clarissa Tio, et al.
Journal of Hypertension
|
May 17, 2017
Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data
Thomas D Giles, John R Cockcroft, Bertram Pitt, et al.
Page
of 69